Page 3 - Daniel Geiger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MagnetOs ™ Granules becomes the third product in the MagnetOs portfolio to receive FDA clearance to market for interbody useKuros continues expansion of the MagnetOs franchise with launch of MagnetOs Granules and MagnetOs Putty in New Zealand via an exclusive distribution agreement with Vortek Spine Limited, a high-...

Kuros Biosciences AG / Key word(s): Study/Study results27-Dec-2023 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal...

In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in a difficult-to-treat real life patient population (20% smokers). In the STRUCTURE trial, MagnetOs mixed with autograft showed posterolateral fusion rates comparable to autograft fusion rates in the le...

Forward thinkers 35 and under at major real-estate firms and innovative startups are tackling issues from housing affordability to the climate crisis.

Kuros Biosciences AG / Key word: Regulatory Approval Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages 28.11.2023 / 18:00...